ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Wednesday reported a loss of $61.9 million in its third quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of $1.41.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.44 per share.
Advertisement
The biotechnology company posted revenue of $28.9 million in the period, falling short of Street forecasts. Five analysts surveyed by Zacks expected $30.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGNX at https://www.zacks.com/ap/RGNX